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Introduction:  
 Atrial fibrillation is independently associated 
with up to a two-fold higher risk of death. 
Recently studies highlight that inflammation 
plays a key role in the initiation, keeping and 
recurrence of atrial fibrillation. 
Purpose:  
To study the importance of inflammatory 
biomarkers, such as C-reactive protein (CRP) and 
neutrophil-lymphocyte ratio (RNL), for the risk of 
severe complications in patients with non-valvular 
atrial fibrillation. 
Material and methods:  
Blood samples were collected in both groups in EDTA and gel-separator tubes, 
immediately centrifuged. PCR - levels were determined with high-sensitivity 
immunoassays on the ARCHITECT i8000SR (Abbott Diagnostics) and NLR - levels 






Conclusions: We can mention the importance of RNL and CRP values ​​in 
identifying patients at increased risk of complications in non-valvular 
atrial fibrillation, by simple and inexpensive methods in laboratory 
diagnosis.  
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The mean of inflammatory biomarker 
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  GS GC 
Women 6,46±0.93 mg/l 11,09±2.82 mg/l 











The mean of NLR 
  GS  GC  
Women 2.49 ± 0.31 2.68 ± 0.34 
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